Tumor microenvironment (TME) expression profiles guide our understanding of the interactions between malignant and non-malignant cells. Multiplex immunofluorescence enables the tracking of multiple markers within the TME, which improves therapeutic response predictions and identifies potential new therapeutic targets.

This poster explores multiplex immunofluorescence, how it differs from traditional immunohistochemistry applications and the advantages of this method.

This content was provided by

Follow Fortis Life Sciences on Twitter and on LinkedIn.